Supplementary table-1.docx (18.05 kB)
Supplementary Tables – Pregnancy and perinatal outcomes following exposure to antineoplastic agents around pregnancy within the US FDA Adverse Event Reporting System
dataset
posted on 2022-05-25, 08:37 authored by Figshare Future Science GroupFigshare Future Science Group, Omar Abdel-Rahman, Sunita GhoshList of antineoplastic agents included in the current analysis
